Unlock the US Election Countdown newsletter for free
The stories that matter on money and politics in the race for the White House
Covering weight-loss drugs for elderly Americans on the state-backed Medicare health insurance programme would cost the US government $35bn over the next nine years, a congressional analysis has found.
Currently, Medicare, which provides prescription drugs to about 54mn over-65s in the US, only covers anti-obesity medications, such as Novo Nordisk’s blockbuster…
Read the full article here